Evaxion Biotech (EVAX) Misses Q3 EPS by 4c

Evaxion Biotech (NASDAQ: EVAX) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $3.01 million.

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• Carlisle Made Unsolicited Offers for Rival Owens Corning - WSJ
• Freedom Broker Upgrades Satellogic, Inc. (SATL) to Buy, 'Growth quality is improving'
• Retrieve Medical signs distribution deal with podiatry network